SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent ...
With a renewed and growing interest in therapeutic oligonucleotides (oligos) across the pharmaceutical industry, the requirements to characterize synthetic oligos have increasingly become more ...
Oligonucleotide therapeutics are revolutionizing modern medicine, but their complex analytical characterization remains a significant challenge for biopharma laboratories. Traditional ion-pairing ...
The 3 billion base pairs that constitute the human genome—the matching jigsaw puzzle pieces of adenine pairing with thymine and cytosine pairing with guanine—are not just the body's instruction manual ...
(MENAFN- EIN Presswire) EINPresswire/ -- The oligonucleotide synthesis services market has experienced robust growth in recent years, driven by advancements in molecular biology and genetic research.
Market research figures compiled by Agilent Technologies reveal that in 2009, $407 million in direct financing was targeted to the development of oligonucleotide therapeutics in the U.S. This figure ...
Serial circulating tumor DNA samples from patients with metastatic breast cancer and BRCA1/2 mutations. Refining neutropenia risk assessment in patients treated with first-line endocrine therapy (ET) ...
Researchers from the University of Oslo have developed an innovative method to improve our understanding of heritable human traits and diseases. The analytical tool, called GSA-MiXeR, is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results